Literature DB >> 426982

Concentration of catecholamines in human cardiac muscle.

M C Petch, W G Nayler.   

Abstract

A trihydroxyindole fluorescent technique was used to measure the concentration of catecholamines in heart muscle taken from 42 patients undergoing open heart surgery. Noradrenaline was the dominant catecholamine and its depletion in the failing heart was confirmed. The distribution of catecholamines within the heart was such that the highest value, 2.64 +/- 0.68 microgram/g, was found in the nonfailing right atrium and the lowest, 0.53 +/- 0.40 microgram/g, in the failing left ventricle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 426982      PMCID: PMC482037          DOI: 10.1136/hrt.41.3.340

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  15 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  CHEMICAL AND HISTOCHEMICAL EVALUATION OF THE DISTRIBUTION OF CATECHOLAMINES IN THE RABBIT AND GUINEA PIG HEARTS.

Authors:  E T ANGELAKOS; K FUXE; M L TORCHIANA
Journal:  Acta Physiol Scand       Date:  1963 Sep-Oct

3.  MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW; D T MASON
Journal:  N Engl J Med       Date:  1963-09-26       Impact factor: 91.245

4.  REGIONAL DISTRIBUTION OF CATECHOLAMINES IN THE DOG HEART.

Authors:  E T ANGELAKOS
Journal:  Circ Res       Date:  1965-01       Impact factor: 17.367

5.  Distribution of norepinephrine in the heart.

Authors:  P A SHORE; V H COHN; B HIGHMAN; H M MALING
Journal:  Nature       Date:  1958-03-22       Impact factor: 49.962

6.  Biochemical analyses of human papillary muscles and guinea pig ventricles in failure.

Authors:  M M Gertler; E Saluste; F Spencer
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

7.  Norepinephrine metabolism in hypertrophied rat hearts.

Authors:  J E Fischer; W D Horst; I J Kopin
Journal:  Nature       Date:  1965-08-28       Impact factor: 49.962

8.  The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.

Authors:  B Lemmer; R Saller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

9.  Determinants of cardiac noradrenaline depletion in human congestive failure.

Authors:  V Dequattro; T Nagatsu; A Mendez; J Verska
Journal:  Cardiovasc Res       Date:  1973-05       Impact factor: 10.787

10.  Uptake of catecholamines by human cardiac muscle in vitro.

Authors:  M C Petch; W G Nayler
Journal:  Br Heart J       Date:  1979-03
View more
  5 in total

1.  Functional differences between junctional and extrajunctional adrenergic receptor activation in mammalian ventricle.

Authors:  Olujimi A Ajijola; Marmar Vaseghi; Wei Zhou; Kentaro Yamakawa; Peyman Benharash; Joseph Hadaya; Robert L Lux; Aman Mahajan; Kalyanam Shivkumar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

2.  Determination of endogenous norepinephrine levels in different chambers of the rat heart by capillary electrophoresis coupled with amperometric detection.

Authors:  Martin Novotny; Veronika Quaiserová-Mocko; Erica A Wehrwein; David L Kreulen; Greg M Swain
Journal:  J Neurosci Methods       Date:  2007-02-16       Impact factor: 2.390

3.  Uptake of catecholamines by human cardiac muscle in vitro.

Authors:  M C Petch; W G Nayler
Journal:  Br Heart J       Date:  1979-03

4.  Histamine release from human right atrium.

Authors:  R W Gristwood; J C Lincoln; D A Owen; I R Smith
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

5.  The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium.

Authors:  L Brown; B Lorenz; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.